Publications found:
205
Sort by:
Expectorant Drugs Market - 2024-2033
US$ 2,999.00
The Expectorant Drugs Market was valued at US$ 108.73 million in 2024 and is anticipated to reach US$ 156.15 million by 2033, at a CAGR of 0.046 from 2026 to 2032. The report delivers in-depth insight...
January 2026
217 pages
Alpha-1 Antitrypsin Deficiency Therapy Market 2026
US$ 2,999.00
The Alpha-1 Antitrypsin Deficiency Therapy Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics,...
December 2025
207 pages
Nasal Polyposis Drugs Market 2026
US$ 2,999.00
The Nasal Polyposis Drugs Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regiona...
December 2025
217 pages
Obesity Hypoventilation Syndrome Treatment Market 2026
US$ 2,999.00
The Obesity Hypoventilation Syndrome Treatment Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynami...
December 2025
220 pages
Pediatric Asthma Treatment Market 2026
US$ 2,999.00
The Pediatric Asthma Treatment Market was valued at in and is anticipated to reach by , at a CAGR of 0.049 from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including...
December 2025
243 pages
Pneumoconiosis Treatment Market 2026
US$ 2,999.00
The Pneumoconiosis Treatment Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regi...
December 2025
223 pages
Reactive Airway Disease Market 2026
US$ 2,999.00
The Reactive Airway Disease Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regio...
December 2025
219 pages
Inhaler Solution Market Size, Share & Trends Analysis Report By Inhaler Type (Pressurized Metered-Dose Inhalers (pMDIs), Dry-Powder Inhalers (DPIs)), By Drug Class, By Application, By Distribution Channel, By Region, And Segment Forecasts, 2026 - 2033
US$ 5,950.00
The global inhaler solution market size was estimated at USD 31.42 billion in 2025 and is projected to reach USD 49.79 billion by 2033, growing at a CAGR of 5.9% from 2026 to 2033. This growth is pri...
December 2025
150 pages
Anti-Pollution Nasal Spray Market Size, Share & Trends Analysis By Product (Pollution Defense Products, Hydrating Nasal Sprays, Symptomatic Relief Nasal Sprays, Cleansing Nasal Sprays), By Distribution Channel, By Region, And Segment Forecasts, 2026 - 2033
US$ 5,950.00
The global anti-pollution nasal spray market size was estimated at USD 8.35 billion in 2025 and is projected to reach USD 13.30 billion by 2033, growing at a CAGR of 6.10% from 2026 to 2033. The high...
December 2025
172 pages
Pneumonia Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Infection Type (Hospital-acquired Pneumonia [HAP], Community-acquired Pneumonia [CAP], Ventilator-associated Pneumonia [VAP]), By Type (Drugs, Preventive Vaccines, Oxygen Therapy), By Drug Class (Antibacterial Drugs, Antiviral Drugs, Antifungal Drugs), By End User (Hospitals and Clinics, Ambulatory Surgical Centers, Others), By Region and Competition, 2020-2030F
US$ 4,500.00
The Global Pneumonia Therapeutics Market will grow from USD 2.91 Billion in 2024 to USD 4.56 Billion by 2030 at a 7.76% CAGR. Pneumonia therapeutics comprise a class of pharmaceutical interventions an...
December 2025
185 pages
Non-Cystic Fibrosis Bronchiectasis Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Treatment (Surgery, Physiotherapy, Vaccination, Airway Pharmacotherapy, Antibiotics, Others), By Diagnosis (CT scan, Bronchoscopy, Chest X-ray, Lung function, Sputum culture test, Blood tests, Others), By End use (Hospitals & Clinics, Ambulatory Care Centers, Others), By Region and Competition, 2020-2030F
US$ 4,500.00
The Global Non-Cystic Fibrosis Bronchiectasis Market, valued at USD 3.71 Billion in 2024, is projected to experience a CAGR of 5.30% to reach USD 5.06 Billion by 2030. The Global Non-Cystic Fibrosis B...
December 2025
185 pages
Respiratory Diagnostics Market- Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Instruments and Devices, Assays & Reagents, Services & Software), By Test Type (Mechanical Tests, OSA Diagnostic Test, Imaging Tests, Traditional Diagnostic Test, Molecular Diagnostic Tests), By Disease Indication (Tuberculosis, Asthma, Lung Cancer, Chronic Obstructive Pulmonary Disease, Others), By End-Use (Hospitals and Clinics, Diagnostics Laboratory, Others), By Region and Competition, 2020-2030F
US$ 4,500.00
The Global Respiratory Diagnostics Market, valued at USD 6.02 Billion in 2024, is projected to experience a CAGR of 7.10% to reach USD 9.09 Billion by 2030. The global respiratory diagnostics market e...
December 2025
185 pages
Acetylcysteine Market 2026
US$ 2,999.00
The Acetylcysteine Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regional growt...
November 2025
218 pages
Acute Lung Injury Market 2026
US$ 2,999.00
The Acute Lung Injury Market was valued at in and is anticipated to reach by , at a CAGR of 0.058 from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regional...
November 2025
223 pages
Asthma and COPD Drug Market 2026
US$ 2,999.00
The Asthma and COPD Drug Market was valued at in and is anticipated to reach by , at a CAGR of 0.039 from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including region...
November 2025
218 pages
Bronchial Spasm Market - 2023-2031
US$ 2,999.00
The Bronchial Spasm Market was valued at US$ 424.36 million in 2023 and is anticipated to reach US$ 650.05 million by 2031, at a CAGR of 0.056 from 2026 to 2032. The report delivers in-depth insights...
November 2025
218 pages
Bronchiectasis Drugs Market 2026
US$ 2,999.00
The Bronchiectasis Drugs Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regional...
November 2025
220 pages
Cough Suppressant Drugs Market 2026
US$ 2,999.00
The Cough Suppressant Drugs Market was valued at in and is anticipated to reach by , at a CAGR of 0.034 from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including reg...
November 2025
210 pages
Erdosteine Market 2026
US$ 2,999.00
The Erdosteine Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regional growth tr...
November 2025
243 pages
Interstitial lung disease (ILD) Market 2026
US$ 2,999.00
The Interstitial lung disease (ILD) Market was valued at in and is anticipated to reach by , at a CAGR of 0.061 from 2026 to 2032. The report delivers in-depth insights into key market dynamics, inclu...
November 2025
220 pages
Lower Respiratory Tract Therapeutics Market - 2022
US$ 2,999.00
The Lower Respiratory Tract Therapeutics Market was valued at USD 32,312.9 million in 2022 and is anticipated to reach by , at a CAGR of 0.073 from 2026 to 2032. The report delivers in-depth insights...
November 2025
219 pages
Pulmonary Edema Therapeutics Market 2026
US$ 2,999.00
The Pulmonary Edema Therapeutics Market was valued at in and is anticipated to reach by , at a CAGR of 0.033 from 2026 to 2032. The report delivers in-depth insights into key market dynamics, includin...
November 2025
223 pages
Acute Respiratory Disease Diagnostics Market Size, Share & Trends Analysis Report By Test (Molecular Diagnostics, Antigen-based Rapid Tests), By Pathogen (Viral Infections, Bacterial Infections), By End-use (Hospitals & Clinics, Home Testing), By Region, And Segment Forecasts, 2025 - 2033
US$ 5,950.00
The global acute respiratory disease diagnostics market size was estimated at USD 5.49 billion in 2024 and is projected to reach USD 10.71 billion by 2033, growing at a CAGR of 7.01% from 2025 to 2033...
November 2025
150 pages
Respiratory Disorders Market - 2024-2033
US$ 2,999.00
The Respiratory Disorders Market was valued at US$ 121.06 Billion in 2024 and is anticipated to reach US$ 213.12 Billion by 2033, at a CAGR of 0.066 from 2026 to 2032. The report delivers in-depth ins...
November 2025
210 pages
Global Cystic Fibrosis (CF) Therapeutics Market - 2023-2033
US$ 2,999.00
The Global Cystic Fibrosis (CF) Therapeutics Market was valued at US$ 9.22 billion in 2023 and is anticipated to reach US$ 35.09 billion by 2033, at a CAGR of 0.142 from 2026 to 2032. The report deliv...
November 2025
213 pages
Pulmonary Arterial Hypertension Market Size, Share & Trends Analysis Report By Drug Class, By Type (Branded, Generics), By Route of Administration (Oral, Intravenous/Subcutaneous, Inhalational), By Region, And Segment Forecasts, 2025 - 2033
US$ 5,950.00
The global pulmonary arterial hypertension market size is expected to reach USD 9.3 billion by 2026, according to a new report ... the development of PAH foster the regional market growth Major players operating in the pulmonary arterial hypertension market include GlaxoSmithKline Plc.; Actelion Pharmaceuticals, ...
November 2025
150 pages
U.S. Asthma Therapeutics Market Size, Share & Trends Analysis Report By Drug Class (Anti-inflammatory, Bronchodilators), By Device Type (Inhalers, Nebulizers), By Route of Administration (Oral, Inhaled), By Product, And Segment Forecasts, 2025 - 2033
US$ 5,950.00
The U.S. asthma therapeutics market size was estimated at USD 13.00 billion in 2024 and is projected to reach USD 19.20 billion by 2033, growing at a CAGR of 4.5% from 2025 to 2033. The rising number...
October 2025
100 pages
Acute Respiratory Distress Syndrome (Ards) Market Outlook 2025-2034: Market Share, and Growth Analysis By Type (Diagnosis, Treatment), By Cause (COVID-19 Disease 2019 (COVID-19), Sepsis, Inhalation Of Harmful Substances, Severe Pneumonia, Other Causes), By Severity, By End User
US$ 3,950.00
The Acute Respiratory Distress Syndrome (Ards) Market is valued at USD 1.8 billion in 2025 and is projected to grow at a CAGR of 10.5% to reach USD 4.4 billion by 2034.The acute respiratory distress s...
October 2025
160 pages
Chronic Obstructive Pulmonary Disease (Copd) Treatment Market Outlook 2025-2034: Market Share, and Growth Analysis By Drug Class (Combination Therapy, Bronchodilators, Corticosteroids, Phosphodiesterase Type 4 Inhibitor, Mucokinetics, Other Drug Classes), By Type (Chronic Bronchitis, Emphysema), By End-User
US$ 3,950.00
The Chronic Obstructive Pulmonary Disease (Copd) Treatment Market is valued at USD 18.6 billion in 2025 and is projected to grow at a CAGR of 4.8% to reach USD 28.2 billion by 2034.The Chronic Obstruc...
October 2025
160 pages
Emphysema Treatment Market Outlook 2025-2034: Market Share, and Growth Analysis By Treatment (Smoking Cessation, Bronchodilators, Steroids, Leukotriene Modifiers, Supplemental Oxygen, Antibiotics, Gene Therapy, Surgery Transplant, Other Treatments), By Distribution Channel (Online Providers, Drug Stores and Retail Pharmacies, Hospital Pharmacies), By End-User
US$ 3,950.00
The Emphysema Treatment Market is valued at USD 7 billion in 2025 and is projected to grow at a CAGR of 6.8% to reach USD 12.6 billion by 2034. Market Overview: Emphysema Treatment Market The emphysem...
October 2025
160 pages
Anti-Asthmatics And Copd Drugs Market Outlook 2025-2034: Market Share, and Growth Analysis By Drug Class (Bronchodilators, Anti-Inflammatory Drugs, Monoclonal Antibodies, Combination Drugs), By Distribution Channel (Hospital Pharmacies, General Pharmacies, Online Retailers), By End User, By Therapy, By Route Of Administration, By Age Group
US$ 3,950.00
The Anti-Asthmatics And Copd Drugs Market is valued at USD 69.6 billion in 2025 and is projected to grow at a CAGR of 6% to reach USD 117.6 billion by 2034.The Anti-Asthmatic and COPD Drugs Market foc...
October 2025
160 pages
Asthma Drugs Market Outlook 2025-2034: Market Share, and Growth Analysis By Type Of Asthma (Allergic, Non-Allergic), By Asthma Trigger Type (Adult-Onset Asthma, Child-Onset Asthma, Cough-Induced Asthma, Exercise-Induced Asthma, Occupational Asthma, Nocturnal Asthma, Steroid-Resistant Asthma), By Therapy, By Drug Class, By End-User
US$ 3,950.00
The Asthma Drugs Market is valued at USD 20.9 billion in 2025 and is projected to grow at a CAGR of 4.7% to reach USD 31.5 billion by 2034. Asthma Drugs Market The asthma drugs market continues to exp...
October 2025
160 pages
Inhaled Antibiotics Market Outlook 2025-2034: Market Share, and Growth Analysis By Product Type( Aerosol or Metered Dose Inhaler, Dry Powder Formulation, Spray, Other Types), By Application( Pneumonia, Asthma, Bronchitis, Other Applications), By End-User
US$ 3,950.00
The Inhaled Antibiotics Market is valued at USD 2.1 billion in 2025 and is projected to grow at a CAGR of 7.5% to reach USD 4 billion by 2034.The inhaled antibiotics market focuses on the development...
October 2025
160 pages
Respiratory Syncytial Virus (Rsv) Therapeutics Market Outlook 2025-2034: Market Share, and Growth Analysis By Drug (Palivizumab, Ribavirin, Other Drugs), By Treatment (Immune Prophylaxis, Supportive Care, Antiviral Medications), By Dosage Form, By Patient Type, By Distribution Channel
US$ 3,950.00
The Respiratory Syncytial Virus (Rsv) Therapeutics Market is valued at USD 2.3 billion in 2025 and is projected to grow at a CAGR of 20.7% to reach USD 12.5 billion by 2034.The Respiratory Syncytial V...
October 2025
160 pages
Severe Acute Respiratory-Syndrome Treatment Market Outlook 2025-2034: Market Share, and Growth Analysis By Drug Class (Antibiotics, Antiviral, Corticosteroids, Monoclonal Antibodies, Other Drug Classes), By Route Of Administration (Oral, Intravenous), By Indication, By Distribution Channel
US$ 3,950.00
The Severe Acute Respiratory-Syndrome Treatment Market is valued at USD 4.6 billion in 2025 and is projected to grow at a CAGR of 15.9% to reach USD 17.4 billion by 2034.The Severe Acute Respiratory S...
October 2025
160 pages
Global Pneumonia Treatment Drugs Market Growth 2025-2031
US$ 3,660.00
... the growth prospects of global Pneumonia Treatment Drugs market for 2018-2023. This report presents a comprehensive overview, market shares, and growth opportunities of Pneumonia Treatment Drugs market by product type, application ...
October 2025
118 pages
Global Tuberculosis Treatment Drugs Market Growth 2025-2031
US$ 3,660.00
... the growth prospects of global Tuberculosis Treatment Drugs market for 2018-2023. This report presents a comprehensive overview, market shares, and growth opportunities of Tuberculosis Treatment Drugs market by product type, application ...
October 2025
102 pages
Global Alpha1-Proteinase Inhibitor Market Growth 2025-2031
US$ 3,660.00
The global Alpha1-Proteinase Inhibitor market size is predicted to grow from US$ 8677 million in 2025 to US$ 10060 million in 2031; it is expected to grow at a CAGR of 2.5% from 2025 to 2031. The impa...
October 2025
96 pages
